Cargando…
Correction to: T cell leukemia control via Ras-Raf pathway inhibition with peptides
In the original publication, the authors’ names and their affiliations have been incorrectly typeset. The original article is now corrected.
Autores principales: | Marin, GH, Rebollo, A, Bruzzoni-Giovanelli, H, Schinella, G, Piazzon, I, Duarte, A, Errecalde, J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Carol Davila University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909951/ https://www.ncbi.nlm.nih.gov/pubmed/29697701 |
Ejemplares similares
-
T cell leukemia control via Ras-Raf pathway
inhibition with peptides
por: Marin, G, et al.
Publicado: (2017) -
Ras and Raf pathways in epidermis development and carcinogenesis
por: Kern, F, et al.
Publicado: (2011) -
Ras and Raf pathways in epidermis development and carcinogenesis
por: Kern, F, et al.
Publicado: (2011) -
Peptide V3 Inhibits the Growth of Human Hepatocellular Carcinoma by Inhibiting the Ras/Raf/MEK/ERK Signaling Pathway
por: Wu, Dongdong, et al.
Publicado: (2019) -
RAF inhibitors promote RAS-RAF interaction by allosterically disrupting RAF autoinhibition
por: Jin, Ting, et al.
Publicado: (2017)